152 related articles for article (PubMed ID: 34843858)
21. Gender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: results from the ESC-EORP EUROASPIRE surveys.
Ferrannini G; De Bacquer D; Vynckier P; De Backer G; Gyberg V; Kotseva K; Mellbin L; Norhammar A; Tuomilehto J; Wood D; Rydén L;
Cardiovasc Diabetol; 2021 Feb; 20(1):38. PubMed ID: 33573665
[TBL] [Abstract][Full Text] [Related]
22. Fluctuation between fasting and 2-H postload glucose state is associated with chronic kidney disease in previously diagnosed type 2 diabetes patients with HbA1c ≥ 7%.
Wang C; Song J; Ma Z; Yang W; Li C; Zhang X; Hou X; Sun Y; Lin P; Liang K; Gong L; Wang M; Liu F; Li W; Yan F; Yang J; Wang L; Tian M; Liu J; Zhao R; Chen L
PLoS One; 2014; 9(7):e102941. PubMed ID: 25047354
[TBL] [Abstract][Full Text] [Related]
23. Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects.
Ko GT; Chan JC; Yeung VT; Chow CC; Tsang LW; Li JK; So WY; Wai HP; Cockram CS
Diabetes Care; 1998 Aug; 21(8):1221-5. PubMed ID: 9702423
[TBL] [Abstract][Full Text] [Related]
24. Impaired glucose regulation in adults in Jamaica: who should have the oral glucose tolerance test?
Sargeant LA; Boyne MS; Bennett FI; Forrester TE; Cooper RS; Wilks RJ
Rev Panam Salud Publica; 2004 Jul; 16(1):35-42. PubMed ID: 15333264
[TBL] [Abstract][Full Text] [Related]
25. Performance indicators and validity of serum fructosamine assay as a diagnostic test in a screening program for diabetes mellitus.
Mula-Abed WA; Al-Naemi AH
Saudi Med J; 2003 May; 24(5):477-84. PubMed ID: 12847621
[TBL] [Abstract][Full Text] [Related]
26. Using HbA(1c) to improve efficacy of the american diabetes association fasting plasma glucose criterion in screening for new type 2 diabetes in American Indians: the strong heart study.
Wang W; Lee ET; Fabsitz R; Welty TK; Howard BV
Diabetes Care; 2002 Aug; 25(8):1365-70. PubMed ID: 12145236
[TBL] [Abstract][Full Text] [Related]
27. The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging.
Meigs JB; Muller DC; Nathan DM; Blake DR; Andres R;
Diabetes; 2003 Jun; 52(6):1475-84. PubMed ID: 12765960
[TBL] [Abstract][Full Text] [Related]
28. Differences in height explain gender differences in the response to the oral glucose tolerance test- the AusDiab study.
Sicree RA; Zimmet PZ; Dunstan DW; Cameron AJ; Welborn TA; Shaw JE
Diabet Med; 2008 Mar; 25(3):296-302. PubMed ID: 18307457
[TBL] [Abstract][Full Text] [Related]
29. Combined use of fasting plasma glucose and HbA1c predicts the progression to diabetes in Chinese subjects.
Ko GT; Chan JC; Tsang LW; Cockram CS
Diabetes Care; 2000 Dec; 23(12):1770-3. PubMed ID: 11128350
[TBL] [Abstract][Full Text] [Related]
30. HbA₁c versus oral glucose tolerance test as a method to diagnose diabetes mellitus in vascular surgery patients.
Hjellestad ID; Astor MC; Nilsen RM; Søfteland E; Jonung T
Cardiovasc Diabetol; 2013 May; 12():79. PubMed ID: 23705980
[TBL] [Abstract][Full Text] [Related]
31. Implications of the Hemoglobin Glycation Index on the Diagnosis of Prediabetes and Diabetes.
Hsia DS; Rasouli N; Pittas AG; Lary CW; Peters A; Lewis MR; Kashyap SR; Johnson KC; LeBlanc ES; Phillips LS; Hempe JM; Desouza CV;
J Clin Endocrinol Metab; 2020 Mar; 105(3):e130-8. PubMed ID: 31965161
[TBL] [Abstract][Full Text] [Related]
32. Fasting plasma glucose in the screening for type 2 diabetes in morbidly obese subjects.
Hofsø D; Jenssen T; Hager H; Røislien J; Hjelmesaeth J
Obes Surg; 2010 Mar; 20(3):302-7. PubMed ID: 19949889
[TBL] [Abstract][Full Text] [Related]
33. Fasting plasma glucose and risk factor assessment: Comparing sensitivity and specificity in identifying gestational diabetes in urban black African women.
Dickson LM; Buchmann EJ; Janse van Rensburg C; Norris SA
S Afr Med J; 2019 Dec; 110(1):21-26. PubMed ID: 31865938
[TBL] [Abstract][Full Text] [Related]
34. The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality: data from the Baltimore Longitudinal Study of Aging with a critical review of the literature.
Sorkin JD; Muller DC; Fleg JL; Andres R
Diabetes Care; 2005 Nov; 28(11):2626-32. PubMed ID: 16249530
[TBL] [Abstract][Full Text] [Related]
35. Cardiometabolic importance of 1-h plasma glucose in obese subjects.
Haverals L; Van Dessel K; Verrijken A; Dirinck E; Peiffer F; Verhaegen A; De Block C; Van Gaal L
Nutr Diabetes; 2019 May; 9(1):16. PubMed ID: 31127083
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the Current Diagnostic Criterion of HbA1c with Fasting and 2-Hour Plasma Glucose Concentration.
Karnchanasorn R; Huang J; Ou HY; Feng W; Chuang LM; Chiu KC; Samoa R
J Diabetes Res; 2016; 2016():6195494. PubMed ID: 27597979
[TBL] [Abstract][Full Text] [Related]
37. Comparing HbA1c, fasting and 2-h plasma glucose for screening for abnormal glucose regulation in patients undergoing coronary angiography.
Wang JS; Lee IT; Lee WJ; Lin SY; Fu CP; Lee WL; Liang KW; Sheu WH
Clin Chem Lab Med; 2015 Aug; 53(9):1441-9. PubMed ID: 25405720
[TBL] [Abstract][Full Text] [Related]
38. One-hour plasma glucose combined with skin autofluorescence identifies subjects with pre-diabetes: the DIAPASON study.
La Sala L; Tagliabue E; de Candia P; Prattichizzo F; Ceriello A
BMJ Open Diabetes Res Care; 2020 Sep; 8(1):. PubMed ID: 32928791
[TBL] [Abstract][Full Text] [Related]
39. Screening for new-onset diabetes after kidney transplantation: limitations of fasting glucose and advantages of afternoon glucose and glycated hemoglobin.
Yates CJ; Fourlanos S; Colman PG; Cohney SJ
Transplantation; 2013 Oct; 96(8):726-31. PubMed ID: 23902993
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of 1-hour postload plasma glucose as a suitable measurement in predicting type 2 diabetes and diabetes-related complications: A post hoc analysis of the 30-year follow-up of the Da Qing IGT and Diabetes Study.
Peng M; He S; Wang J; An Y; Qian X; Zhang B; Zhang L; Chen B; Yang Z; Li G; Gong Q;
Diabetes Obes Metab; 2024 Jun; 26(6):2329-2338. PubMed ID: 38488254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
